AAPL331.90-6.42 (-1.90%) ▼|ABBV286.00-2.84 (-0.98%) ▼|ABT109.40-0.76 (-0.69%) ▼|ACN254.56-6.38 (-2.45%) ▼|ADBE246.14-5.33 (-2.12%) ▼|AMAT381.92+7.39 (+1.97%) ▲|AMD483.90+17.06 (+3.65%) ▲|AMGN461.26-4.19 (-0.90%) ▼|AMT187.29-1.01 (-0.54%) ▼|AMZN250.69+5.06 (+2.06%) ▲|AVGO332.13+9.90 (+3.07%) ▲|AXP325.50-2.48 (-0.76%) ▼|BA173.31-2.09 (-1.19%) ▼|BAC49.66+0.09 (+0.18%) ▲|BKNG155.67+1.92 (+1.25%) ▲|BLK1,161.32-5.83 (-0.50%) ▼|BMY61.71-1.31 (-2.08%) ▼|BNY149.31+1.53 (+1.04%) ▲|BRK-B557.07+0.96 (+0.17%) ▲|C122.71-0.39 (-0.32%) ▼|CAT623.94+10.32 (+1.68%) ▲|CL95.62-1.81 (-1.86%) ▼|CMCSA23.67-0.20 (-0.84%) ▼|COF208.71-2.06 (-0.98%) ▼|COP144.40-2.44 (-1.66%) ▼|COST1,019.26-21.29 (-2.05%) ▼|CRM222.20-3.98 (-1.76%) ▼|CSCO102.97+1.36 (+1.34%) ▲|CVS91.41+2.90 (+3.28%) ▲|CVX225.27-2.50 (-1.10%) ▼|DE665.83-1.77 (-0.27%) ▼|DHR230.11+2.14 (+0.94%) ▲|DIS114.18+1.07 (+0.95%) ▲|DUK126.51-1.87 (-1.46%) ▼|EMR166.39+0.43 (+0.26%) ▲|FDX318.02-0.23 (-0.07%) ▼|GD374.50+1.04 (+0.28%) ▲|GE320.67+4.89 (+1.55%) ▲|GEV918.20+55.95 (+6.49%) ▲|GILD167.47-2.86 (-1.68%) ▼|GM88.34-1.60 (-1.78%) ▼|GOOG278.27+0.23 (+0.08%) ▲|GOOGL280.03+1.04 (+0.37%) ▲|GS896.09-2.63 (-0.29%) ▼|HD333.66-7.49 (-2.20%) ▼|HON224.05+0.28 (+0.13%) ▲|IBM250.04-2.47 (-0.98%) ▼|INTC60.55+0.58 (+0.97%) ▲|INTU344.72-7.38 (-2.10%) ▼|ISRG440.75+3.88 (+0.89%) ▲|JNJ266.17-4.39 (-1.62%) ▼|JPM337.98-2.60 (-0.76%) ▼|KO94.80-1.03 (-1.07%) ▼|LIN511.55-8.17 (-1.57%) ▼|LLY1,409.38-1.61 (-0.11%) ▼|LMT639.00-4.15 (-0.65%) ▼|LOW213.38-4.77 (-2.19%) ▼|LRCX230.72+3.16 (+1.39%) ▲|MA647.18-10.92 (-1.66%) ▼|MCD263.04-2.60 (-0.98%) ▼|MDLZ65.12-1.26 (-1.90%) ▼|MDT98.88-0.41 (-0.41%) ▼|META621.03+14.30 (+2.36%) ▲|MMM177.05-1.31 (-0.73%) ▼|MO76.94-0.23 (-0.30%) ▼|MRK144.67-3.69 (-2.49%) ▼|MS186.09+0.36 (+0.19%) ▲|MSFT520.99+13.87 (+2.74%) ▲|MU855.10+21.51 (+2.58%) ▲|NEE84.33-0.70 (-0.82%) ▼|NFLX63.42+1.08 (+1.73%) ▲|NKE38.48-0.64 (-1.64%) ▼|NOW109.16+3.15 (+2.97%) ▲|NVDA206.69+4.63 (+2.29%) ▲|ORCL126.19+6.97 (+5.85%) ▲|PEP137.27-3.15 (-2.24%) ▼|PFE30.00-0.67 (-2.18%) ▼|PG162.06-1.50 (-0.92%) ▼|PLTR175.40-2.94 (-1.65%) ▼|PM208.03-0.26 (-0.12%) ▼|QCOM164.43+2.35 (+1.45%) ▲|RTX203.82+1.03 (+0.51%) ▲|SBUX104.77+0.37 (+0.35%) ▲|SCHW89.28+0.57 (+0.64%) ▲|SO93.75-0.86 (-0.91%) ▼|SPG222.08+0.35 (+0.16%) ▲|T21.39-0.05 (-0.23%) ▼|TMO698.34+15.69 (+2.30%) ▲|TMUS154.41-5.74 (-3.58%) ▼|TSLA398.50-5.32 (-1.32%) ▼|TXN312.49+10.47 (+3.47%) ▲|UBER66.60-0.11 (-0.16%) ▼|UNH404.44+4.00 (+1.00%) ▲|UNP303.43-3.57 (-1.16%) ▼|UPS109.17-0.54 (-0.49%) ▼|USB59.89-0.60 (-0.99%) ▼|V420.42-5.09 (-1.20%) ▼|VZ45.24+0.19 (+0.42%) ▲|WFC85.53-0.36 (-0.42%) ▼|WMT124.86-2.83 (-2.22%) ▼|XOM177.46-2.21 (-1.23%) ▼|AAPL331.90-6.42 (-1.90%) ▼|ABBV286.00-2.84 (-0.98%) ▼|ABT109.40-0.76 (-0.69%) ▼|ACN254.56-6.38 (-2.45%) ▼|ADBE246.14-5.33 (-2.12%) ▼|AMAT381.92+7.39 (+1.97%) ▲|AMD483.90+17.06 (+3.65%) ▲|AMGN461.26-4.19 (-0.90%) ▼|AMT187.29-1.01 (-0.54%) ▼|AMZN250.69+5.06 (+2.06%) ▲|AVGO332.13+9.90 (+3.07%) ▲|AXP325.50-2.48 (-0.76%) ▼|BA173.31-2.09 (-1.19%) ▼|BAC49.66+0.09 (+0.18%) ▲|BKNG155.67+1.92 (+1.25%) ▲|BLK1,161.32-5.83 (-0.50%) ▼|BMY61.71-1.31 (-2.08%) ▼|BNY149.31+1.53 (+1.04%) ▲|BRK-B557.07+0.96 (+0.17%) ▲|C122.71-0.39 (-0.32%) ▼|CAT623.94+10.32 (+1.68%) ▲|CL95.62-1.81 (-1.86%) ▼|CMCSA23.67-0.20 (-0.84%) ▼|COF208.71-2.06 (-0.98%) ▼|COP144.40-2.44 (-1.66%) ▼|COST1,019.26-21.29 (-2.05%) ▼|CRM222.20-3.98 (-1.76%) ▼|CSCO102.97+1.36 (+1.34%) ▲|CVS91.41+2.90 (+3.28%) ▲|CVX225.27-2.50 (-1.10%) ▼|DE665.83-1.77 (-0.27%) ▼|DHR230.11+2.14 (+0.94%) ▲|DIS114.18+1.07 (+0.95%) ▲|DUK126.51-1.87 (-1.46%) ▼|EMR166.39+0.43 (+0.26%) ▲|FDX318.02-0.23 (-0.07%) ▼|GD374.50+1.04 (+0.28%) ▲|GE320.67+4.89 (+1.55%) ▲|GEV918.20+55.95 (+6.49%) ▲|GILD167.47-2.86 (-1.68%) ▼|GM88.34-1.60 (-1.78%) ▼|GOOG278.27+0.23 (+0.08%) ▲|GOOGL280.03+1.04 (+0.37%) ▲|GS896.09-2.63 (-0.29%) ▼|HD333.66-7.49 (-2.20%) ▼|HON224.05+0.28 (+0.13%) ▲|IBM250.04-2.47 (-0.98%) ▼|INTC60.55+0.58 (+0.97%) ▲|INTU344.72-7.38 (-2.10%) ▼|ISRG440.75+3.88 (+0.89%) ▲|JNJ266.17-4.39 (-1.62%) ▼|JPM337.98-2.60 (-0.76%) ▼|KO94.80-1.03 (-1.07%) ▼|LIN511.55-8.17 (-1.57%) ▼|LLY1,409.38-1.61 (-0.11%) ▼|LMT639.00-4.15 (-0.65%) ▼|LOW213.38-4.77 (-2.19%) ▼|LRCX230.72+3.16 (+1.39%) ▲|MA647.18-10.92 (-1.66%) ▼|MCD263.04-2.60 (-0.98%) ▼|MDLZ65.12-1.26 (-1.90%) ▼|MDT98.88-0.41 (-0.41%) ▼|META621.03+14.30 (+2.36%) ▲|MMM177.05-1.31 (-0.73%) ▼|MO76.94-0.23 (-0.30%) ▼|MRK144.67-3.69 (-2.49%) ▼|MS186.09+0.36 (+0.19%) ▲|MSFT520.99+13.87 (+2.74%) ▲|MU855.10+21.51 (+2.58%) ▲|NEE84.33-0.70 (-0.82%) ▼|NFLX63.42+1.08 (+1.73%) ▲|NKE38.48-0.64 (-1.64%) ▼|NOW109.16+3.15 (+2.97%) ▲|NVDA206.69+4.63 (+2.29%) ▲|ORCL126.19+6.97 (+5.85%) ▲|PEP137.27-3.15 (-2.24%) ▼|PFE30.00-0.67 (-2.18%) ▼|PG162.06-1.50 (-0.92%) ▼|PLTR175.40-2.94 (-1.65%) ▼|PM208.03-0.26 (-0.12%) ▼|QCOM164.43+2.35 (+1.45%) ▲|RTX203.82+1.03 (+0.51%) ▲|SBUX104.77+0.37 (+0.35%) ▲|SCHW89.28+0.57 (+0.64%) ▲|SO93.75-0.86 (-0.91%) ▼|SPG222.08+0.35 (+0.16%) ▲|T21.39-0.05 (-0.23%) ▼|TMO698.34+15.69 (+2.30%) ▲|TMUS154.41-5.74 (-3.58%) ▼|TSLA398.50-5.32 (-1.32%) ▼|TXN312.49+10.47 (+3.47%) ▲|UBER66.60-0.11 (-0.16%) ▼|UNH404.44+4.00 (+1.00%) ▲|UNP303.43-3.57 (-1.16%) ▼|UPS109.17-0.54 (-0.49%) ▼|USB59.89-0.60 (-0.99%) ▼|V420.42-5.09 (-1.20%) ▼|VZ45.24+0.19 (+0.42%) ▲|WFC85.53-0.36 (-0.42%) ▼|WMT124.86-2.83 (-2.22%) ▼|XOM177.46-2.21 (-1.23%) ▼|
16 C
New York
Wednesday, November 4, 2026

Tag: Regulatory

Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors

Veteran clinical leader with successful track record and experience to help guide the Company’s clinical strategy in Fibrostenotic Crohn’s Disease and Ulcerative Colitis

Global Water Resources Acquires Seven Water Systems from Tucson Water, Adding 2,200 Customer Connections

PHOENIX, July 09, 2025 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure-play water resource management company, has completed the previously announced acquisition of seven water systems from Tucson Water, the City of Tucson’s water utility. The assets were acquired at a value equivalent to approximately 1.05 times the current rate base of approximately $7.7 million and are expected to generate approximately $1.5 million in revenue annually.

DeFi Dev Corp. Integrates DoubleZero Into Validator Operations

BOCA RATON, FL, July 09, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”) the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced it has integrated DoubleZero into its validator operations. This marks an early step in evaluating advanced observability and monitoring solutions designed to improve validator performance and network resilience.

Bandwidth Powers Pennymac Cloud Migration To 50 Percent Cost Savings, Faster Loan Closings

Top U.S. mortgage lender, featured in American Banker article, leverages Bandwidth's platform for dramatic efficiency gains, enhanced customer experience and improved compliance RALEIGH, N.C., July...

CYMAT ANNOUNCES ACTIVATION OF ACCELERATED WARRANT EXPIRY DATE

MISSISSAUGA, ON, July 9, 2025 /PRNewswire/ - Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) (the "Company" or "Cymat") is announcing that it is activating...

CYMAT ANNOUNCES ACTIVATION OF ACCELERATED WARRANT EXPIRY DATE

MISSISSAUGA, ON, July 9, 2025 /CNW/ - Cymat Technologies Ltd. (TSXV: CYM) (OTCQB: CYMHF) (the "Company" or "Cymat") is announcing that it is activating...

In-Camera Visual Effects (ICVFX) Market Poised to Reach USD 1.78 Billion by 2032, Accelerating at a Robust CAGR of 12.99%: AnalystView Market Insights

Surging demand for immersive storytelling, real-time virtual production, and reduced post-production costs are driving the ICVFX market, with over 60% of major studios integrating ICVFX in their production pipelines. This shift enhances creative flexibility, accelerates content delivery, and sets new standards for cinematic visual excellence.
Surging demand for immersive storytelling, real-time virtual production, and reduced post-production costs are driving the ICVFX market, with over 60% of major studios integrating ICVFX in their production pipelines. This shift enhances creative flexibility, accelerates content delivery, and sets new standards for cinematic visual excellence.

Atsena Therapeutics Announces Alignment with FDA on Regulatory Pathway to Approval for ATSN-201 in X-Linked Retinoschisis (XLRS)

Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides clear regulatory pathway to approval in a continuous Phase 1 / 2 / 3 study, avoiding the requirement for an additional registrational study and accelerating time to potential approval

ChemPoint Establishes EMEA Headquarters in Dublin, Ireland to Fuel Regional Growth

DUBLIN, July 9, 2025 /PRNewswire/ -- ChemPoint LLC ("ChemPoint"), a subsidiary of Univar Solutions LLC, a leading global solutions provider to users of specialty...

ChemPoint Establishes EMEA Headquarters in Dublin, Ireland to Fuel Regional Growth

DUBLIN, July 9, 2025 /PRNewswire/ -- ChemPoint LLC ("ChemPoint"), a subsidiary of Univar Solutions LLC, a leading global solutions provider to users of specialty...

Copper Tubes Market worth $42.62 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 9, 2025 /PRNewswire/ -- The report "Copper Tubes Market by Type (Type K, Type L, Type M, Other Types), Form (Straight...

Guidehouse Research Explores Landscape for Medium and Heavy Duty On-Highway Vehicles

Can hybrid drivelines play a role in the decarbonization of the MDHD truck sector BOULDER, Colo., July 9, 2025 /PRNewswire/ -- A new report from Guidehouse Research discusses...

Viral Vectors & Plasmid DNA Manufacturing Market Report 2025-2035 | Gene Therapy Boom Fuels Demand, Regulatory Hurdles Challenge Growth in Gene Therapy Manufacturing

The Viral Vectors and Plasmid DNA Manufacturing Market forecast indicates a surge past $6 billion by 2025, driven by gene therapy advancements. The report highlights market dynamics, growth prospects, and regulatory challenges impacting this sector. Discover innovative opportunities and key players in this evolving landscape.
The Viral Vectors and Plasmid DNA Manufacturing Market forecast indicates a surge past $6 billion by 2025, driven by gene therapy advancements. The report highlights market dynamics, growth prospects, and regulatory challenges impacting this sector. Discover innovative opportunities and key players in this evolving landscape.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRegulatory